![Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities - ScienceDirect Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0065242321000639-f06-01-9780323988490.jpg)
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities - ScienceDirect
![Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-021-01180-x/MediaObjects/41375_2021_1180_Fig1_HTML.png)
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia
![IJMS | Free Full-Text | Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States IJMS | Free Full-Text | Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States](https://pub.mdpi-res.com/ijms/ijms-21-05392/article_deploy/html/images/ijms-21-05392-ag.png?1602251690)
IJMS | Free Full-Text | Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States
![Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-018-0163-4/MediaObjects/41375_2018_163_Fig3_HTML.jpg)
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia
![IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases](https://www.mdpi.com/ijms/ijms-24-09531/article_deploy/html/images/ijms-24-09531-g001.png)
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
![Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research](https://pubs.acs.org/cms/10.1021/acs.jproteome.5b00711/asset/images/medium/pr-2015-00711n_0008.gif)
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
![Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management | Blood Cancer Journal Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-020-00370-7/MediaObjects/41408_2020_370_Fig4_HTML.png)
Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management | Blood Cancer Journal
![Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management - The Lancet Haematology Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management - The Lancet Haematology](https://www.thelancet.com/cms/attachment/5cf03239-b043-450f-8cf1-1b731c69c8d6/gr3.jpg)
Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management - The Lancet Haematology
![Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis](https://www.frontiersin.org/files/MyHome%20Article%20Library/974392/974392_Thumb_400.jpg)
Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis
![Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-018-0163-4/MediaObjects/41375_2018_163_Fig1_HTML.jpg)
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia
![Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management - The Lancet Haematology Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management - The Lancet Haematology](https://www.thelancet.com/cms/asset/c3d50a63-006a-4501-8cc5-0a07f789038a/gr1.jpg)
Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management - The Lancet Haematology
![Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-018-0163-4/MediaObjects/41375_2018_163_Fig2_HTML.jpg)